Lenz & Staehelin advised Asceneuron in its Series C financing. Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Kartesia on all Swiss tax, financing and corporate aspects of the transaction. Kartesia, a leading European provider of financing solutions for small...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin has advised Volumina Medical in this financing round. Volumina Medical, a clinical stage MedTech company developing novel biomaterials for dermatology and plastic surgery,...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Transmutex on all legal matters. Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, raised over CHF 20M in the extension...
You must be a Standard 1 Year member to access this content.
Travers Smith LLP and Walder Wyss advised Inflexion on the deal. Lenz & Staehelin advised Gyrus Capital in this transaction. Inflexion and Gyrus Capital have announced...
You must be a Standard 1 Year member to access this content.
Homburger advised StoneX in this transaction. Lenz & Staehelin advised CDI’s sole shareholder and seller. StoneX Group Inc. (NASDAQ: SNEX), a global financial services company, announced...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Gyrus Capital in this transaction, alongside with Chiomenti (Italian law) and Wolf Theiss (Albanian law). Consulcesi and Falcon Industrial was advised by...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised beqom SA in this transaction, while Walkers and Weil, Gotshal & Manges LLP assisted Sumeru Equity Partners. beqom, a company sponsored inter...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Transmutex on the deal. The Geneva based cleantech company Transmutex has completed its CHF 5.3 million Series A. This comes a couple...
You must be a Standard 1 Year member to access this content.
